Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 95
- Reported
- 93
- Verified
- 86
- Gap
- +9
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Adopt with guardrails
- Why
- Fully FDA-approved with a Phase 3 OS win (13.6 vs 8.3 mo, HR 0.60) and traditional-approval maturity, but the boxed-warning CRS/ICANS profile plus an inpatient step-up regimen is a hard operational guardrail, reinforced by real-world ICANS exceeding trial rates.
- Next
- Track real-world CRS/ICANS management data and community-site uptake post full-approval; model the DLL3xCD3 bispecific pattern as a reference for T-cell engager monitoring requirements
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 3
- Tier 3
- 4
- Supports
- 3
- Contradicts
- 1
- Context
- 3
- Latest observed
- 2025-11-30
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.